D. E. Shaw & Co., Inc. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$25,140,000
+1167.1%
542,638
+566.7%
0.03%
+933.3%
Q1 2019$1,984,000
+737.1%
81,394
+390.3%
0.00%
Q4 2018$237,000
-57.5%
16,600
-54.7%
0.00%
-100.0%
Q3 2018$557,000
+140.1%
36,643
+157.7%
0.00%
Q1 2018$232,000
-92.3%
14,218
-94.0%
0.00%
-100.0%
Q4 2017$3,026,000
+49.1%
236,436
+43.4%
0.00%
+33.3%
Q3 2017$2,029,000
+1391.9%
164,933
+984.4%
0.00%
Q1 2017$136,000
-2.9%
15,209
-26.5%
0.00%
Q3 2016$140,000
+204.3%
20,681
+34.0%
0.00%
Q1 2016$46,000
-62.0%
15,428
-46.4%
0.00%
Q4 2015$121,000
-2.4%
28,762
+5.9%
0.00%
Q3 2015$124,000
-59.7%
27,159
-34.9%
0.00%
Q1 2015$308,000
-81.7%
41,750
-88.2%
0.00%
-100.0%
Q4 2014$1,679,000
+783.7%
355,069
+836.0%
0.00%
Q4 2013$190,000
-55.4%
37,935
-44.6%
0.00%
-100.0%
Q3 2013$426,000
-82.5%
68,466
-87.2%
0.00%
-80.0%
Q2 2013$2,430,000535,0830.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders